Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodone

Postgraduate Medicine

Volumn 123, Issue 4, 2011, Pages 148-159

  Roland, Carl L ^a   Setnik, Beatrice ^a   Cleveland, Jody M ^a   Brown, David A ^a  

^a King Pharmaceuticals Research and Development Inc   (United States)

Author keywords

Opioids; Oxycodone; Pain; Remoxy

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; DEXTROPROPOXYPHENE NAPSILATE; FENTANYL; HYDROCODONE; LEVORPHANOL; METHADONE; MORPHINE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE; TRAMADOL;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CONSTIPATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; EXTENDED RELEASE FORMULATION; FATIGUE; FEMALE; HUMAN; HYPERTENSION; IMMEDIATE RELEASE FORMULATION; INFLUENZA; INSOMNIA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; POST HOC ANALYSIS; PRURITUS; SOMNOLENCE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYCODONE; PAIN; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960308209     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.07.2314     Document Type: Article

References (18)

1. Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
2. Vissers KC, Besse K, Hans G, Devulder J, Morlion B. Opioid rotation in the management of chronic pain: where is the evidence? Pain Pract. 2010;10(2):85-93.
3. Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage. 2009;38(3):409-417.
4. Miaskowski C, Bair MJ, Chou R, et al. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th ed. New York, NY: American Pain Society; 2008.
5. Vadalouca A, Moka E, Argyra E, Sikioti P, Siafaka I. Opioid rotation in patients with cancer: a review of the current literature. J Opioid Manag. 2008;4(4):213-250.
6. Zamloot M, Chao W, Kang L, Ross J, Fu R. Remoxy: a novel formulation of extended-release oxycodone developed using the ORADUR technology. J Appl Res. 2010;10(3):88-96.
7. Friedmann N, Klutzartiz V, Webster LR. Efficacy and safety of an extended-release oxycodone (Remoxy) formulation in patients with moderate to severe osteoarthritic pain. J Opioid Manag. In press.
8. Friedmann N, Klutzartiz V, Webster LR. Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthitis of low back pain. Pain Med. 2011;12(5):755-760.
9. International Conference on Harmonisation. ICH Guidelines; 2011.
10. Wallace M, Rauck RL, Moulin D, Thipphawong J, Khanna S, Tudor IC. Conversion from standard opioid therapy to once-daily oral extendedrelease hydromorphone in patients with chronic cancer pain. J Int Med Res. 2008;36(2):343-352.
11. Palangio M, Northfelt DW, Portenoy RK, et al. Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extendedrelease hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. J Pain Symptom Manage. 2002;23(5):355-368.
12. Katz N, Rauck R, Ahdieh H, et al. A 12-week, randomized, placebocontrolled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin. 2007;23(1):117-128.
13. Korff MV, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521-527.
14. OxyContin (oxycodone HCl controlled-release tablets) [package insert]. Stamford, CT: Purdue Pharma L.P.; 2010.
15. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149-158.
16. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174(11):1589-1594.
17. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35(2):214-228.
18. DURAGESIC® (Fentanyl Transdermal System) [package insert]. Raritan, NJ: PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc; 2009.